# Transplantation of Fibroblast for Correction of Nasolabial Folds

> **NCT03140319** · PHASE1,PHASE2 · UNKNOWN · sponsor: **SCARM Institute, Tabriz, Iran** · enrollment: 50 (estimated)

## Conditions studied

- Nasolabial Folds
- Skin Aging

## Interventions

- **BIOLOGICAL:** Fibroblast
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03140319
- **Lead sponsor:** SCARM Institute, Tabriz, Iran
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-10
- **Primary completion:** 2021-11-15
- **Final completion:** 2021-12-26
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03140319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03140319, "Transplantation of Fibroblast for Correction of Nasolabial Folds". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03140319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
